Related Experiment Videos
Consensus exercise on domains in psoriatic arthritis
1University of Toronto, Toronto Western Research Institute, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Ontario M5T 2S8, Canada. dafna.gladman@utoronto.ca
Annals of the Rheumatic Diseases
|February 15, 2005
Summary
Developing validated assessment tools for psoriatic arthritis (PsA) is crucial. The GRAPPA group identified key domains including inflammation, skin, and patient-reported outcomes for PsA evaluation.
Area of Science:
- Rheumatology and Immunology
- Dermatology
Background:
- Psoriatic arthritis (PsA) management requires validated assessment tools for clinical trials and longitudinal studies.
- Previous Delphi processes identified potential assessment domains but lacked prioritization and inclusion of skin manifestations.
Framework:
- The GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) initiative identified key domains for PsA assessment.
- Identified domains encompass inflammation (peripheral joints, axial skeleton, physician global assessment), other features (dactylitis, enthesitis), skin and nail involvement, imaging, biomarkers, and patient-derived indices (pain, quality of life, itch, function).
Implementation:
- Domains require further refinement to establish consensus on their importance.
- Development of specific instruments and outcome measures is necessary for each identified domain.
Implications:
- Standardized assessment tools will improve the rigor and comparability of PsA clinical trials and research.
- Comprehensive evaluation incorporating all identified domains will lead to better patient management and understanding of PsA.
- Future research should focus on developing and validating instruments for these critical PsA assessment domains.